NEU 1.46% $12.82 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1281

  1. 191 Posts.
    lightbulb Created with Sketch. 91
    Is anyone else bothered by the completely factually incorrect headliine on NEU in the 'featured news' section of the home page of this website for the last 2 days ? I am . The headline is "Neu dips after Angelman trial results FAIL TO IMPRESS."
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.